CME Group (NASDAQ:CME) Given New $283.00 Price Target at Piper Sandler

CME Group (NASDAQ:CME) had its price objective raised by equities researchers at Piper Sandler from $275.00 to $283.00 in a research note issued on Tuesday,Benzinga reports. The firm currently has an “overweight” rating on the financial services provider’s stock. Piper Sandler’s target price points to a potential upside of 11.02% from the stock’s previous close.

CME has been the topic of several other reports. JPMorgan Chase & Co. raised their price target on shares of CME Group from $209.00 to $212.00 and gave the stock an “underweight” rating in a research note on Thursday, February 13th. Bank of America raised their price objective on CME Group from $200.00 to $219.00 and gave the stock an “underperform” rating in a report on Wednesday, April 2nd. Keefe, Bruyette & Woods upped their price target on shares of CME Group from $256.00 to $257.00 and gave the stock a “market perform” rating in a research report on Friday, February 14th. Barclays upped their target price on CME Group from $263.00 to $279.00 and gave the stock an “equal weight” rating in a research report on Monday. Finally, Erste Group Bank upgraded CME Group to a “strong-buy” rating in a report on Monday, March 17th. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, CME Group currently has a consensus rating of “Hold” and a consensus target price of $246.80.

CME Group Price Performance

Shares of NASDAQ CME opened at $254.90 on Tuesday. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01. CME Group has a one year low of $190.70 and a one year high of $273.42. The company’s fifty day moving average is $252.91 and its two-hundred day moving average is $237.72. The firm has a market capitalization of $91.85 billion, a P/E ratio of 26.52, a PEG ratio of 6.76 and a beta of 0.43.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. Analysts forecast that CME Group will post 10.49 EPS for the current fiscal year.

Insider Activity at CME Group

In other CME Group news, Director Howard J. Siegel sold 10,000 shares of the business’s stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $260.00, for a total transaction of $2,600,000.00. Following the sale, the director now directly owns 21,873 shares in the company, valued at approximately $5,686,980. The trade was a 31.37 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Hilda Harris Piell sold 3,984 shares of the stock in a transaction on Thursday, February 27th. The shares were sold at an average price of $250.47, for a total value of $997,872.48. Following the sale, the insider now owns 27,046 shares of the company’s stock, valued at $6,774,211.62. This trade represents a 12.84 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 27,076 shares of company stock worth $6,871,496 in the last 90 days. 0.30% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On CME Group

Institutional investors have recently bought and sold shares of the stock. Norges Bank acquired a new stake in shares of CME Group during the fourth quarter valued at approximately $1,107,389,000. Price T Rowe Associates Inc. MD raised its holdings in shares of CME Group by 89.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 8,280,785 shares of the financial services provider’s stock worth $1,923,047,000 after acquiring an additional 3,921,278 shares in the last quarter. Raymond James Financial Inc. acquired a new position in CME Group in the 4th quarter worth about $871,063,000. GAMMA Investing LLC lifted its holdings in shares of CME Group by 32,941.0% during the 1st quarter. GAMMA Investing LLC now owns 1,858,887 shares of the financial services provider’s stock valued at $493,144,000 after buying an additional 1,853,261 shares during the last quarter. Finally, Franklin Resources Inc. grew its stake in shares of CME Group by 70.4% in the 3rd quarter. Franklin Resources Inc. now owns 2,427,107 shares of the financial services provider’s stock valued at $544,157,000 after buying an additional 1,003,119 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.